Lucid Diagnostics Inc. Deferred Tax Assets, Operating Loss Carryforwards
Lucid Diagnostics Inc. (LUCD) had Deferred Tax Assets, Operating Loss Carryforwards of $52.85 million as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-25
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $52.85M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $39.47M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $29.06M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.02M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $52.85M 10-K · filed 2026-03-25 |
| 2024-12-31 | $39.47M 10-K · filed 2026-03-25 |
| 2023-12-31 | $29.06M 10-K · filed 2025-03-24 |
| 2022-12-31 | $16.02M 10-K · filed 2024-03-25 |
| 2021-12-31 | $11.02M 10-K · filed 2023-03-14 |
| 2020-12-31 | $4.69M 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |